CD22/CD19 CAR-T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD22/CD19 CAR-T cells, covering 2026-03-24 to 2026-03-24. Get the full timeline:
Most recent: Clinical Trial Update: Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL [Phase 2]